Full Papers
Description of self-efficacy for managing symptoms and emotions in a large rheumatology clinic population
R. Dayno1, M.D. George2, M. Blum3, K. Dequattro4, S. Kolasinksi5, D. Direnzo6
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA. rachel.dayno@gmail.com
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA.
- Section of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Medicine, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, USA.
CER17512
2024 Vol.42, N°11
PI 2175, PF 2182
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 39360370 [PubMed]
Received: 25/01/2024
Accepted : 22/04/2024
In Press: 25/09/2024
Published: 04/11/2024
Abstract
OBJECTIVES:
Self-efficacy is the inner confidence in one’s ability to manage specific goals or tasks. The purpose of this study was to describe self-efficacy for people living with various rheumatologic disease and explore its associations with health-related quality of life (HRQoL).
METHODS:
This study was a retrospective, cross-sectional analysis of patients in a large rheumatology division who had office visits and completed questionnaires from May 2022 to January 2023. Questionnaires included the Patient Reported Outcome Measurement Information System (PROMIS)-29 v2.1 and Self-Efficacy for Managing Symptoms (SE Symptoms) and Emotions (SE Emotions) Computer Adaptive Tests, among others. Rheumatologic diagnosis was confirmed by the rheumatologist at the time of the encounter and additional comorbidities were identified via chart review. Mean PROMIS T-scores were compared across demographics and rheumatologic diagnosis and multivariable linear regression models (MLR) were constructed to explore determinants of self-efficacy.
RESULTS:
There were 1,114 patients who completed office visits during the study timeframe; 401 patients (36%) had complete data. Compared to those with high SE symptoms and SE emotions those with low SE symptoms and SE emotions had significantly worse HRQoL in all PROMIS domains by 5–10 mean T-score units (p<0.001). Fatigue, depression, and pain interference were strong determinants of SE symptoms and fatigue, anxiety, and depression were strong determinants of SE emotions in MLR.
CONCLUSIONS:
Self-efficacy can be easily measured as part of routine clinical care using highly precise and reliable PROMIS measures. Self-efficacy is low amongst patients with rheumatologic diseases followed in a large academic centre for routine care and is highly associated with HRQoL.
